- Home
- SBLX vs HSDT Comparison
SBLX vs HSDT Comparison
Compare SBLX & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBLX
- HSDT
- Stock Information
- Founded
- SBLX 2017
- HSDT N/A
- Country
- SBLX United States
- HSDT United States
- Employees
- SBLX N/A
- HSDT N/A
- Industry
- SBLX Telecommunications Equipment
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SBLX Consumer Discretionary
- HSDT Health Care
- Exchange
- SBLX Nasdaq
- HSDT Nasdaq
- Market Cap
- SBLX 4.1M
- HSDT 4.3M
- IPO Year
- SBLX N/A
- HSDT N/A
- Fundamental
- Price
- SBLX $4.70
- HSDT $6.00
- Analyst Decision
- SBLX
- HSDT Hold
- Analyst Count
- SBLX 0
- HSDT 1
- Target Price
- SBLX N/A
- HSDT N/A
- AVG Volume (30 Days)
- SBLX 105.8K
- HSDT 29.7K
- Earning Date
- SBLX 08-14-2025
- HSDT 08-14-2025
- Dividend Yield
- SBLX N/A
- HSDT N/A
- EPS Growth
- SBLX N/A
- HSDT N/A
- EPS
- SBLX N/A
- HSDT N/A
- Revenue
- SBLX $5,426.00
- HSDT $295,000.00
- Revenue This Year
- SBLX N/A
- HSDT N/A
- Revenue Next Year
- SBLX N/A
- HSDT $75.13
- P/E Ratio
- SBLX N/A
- HSDT N/A
- Revenue Growth
- SBLX N/A
- HSDT N/A
- 52 Week Low
- SBLX $4.61
- HSDT $5.37
- 52 Week High
- SBLX $15.28
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- SBLX N/A
- HSDT 28.34
- Support Level
- SBLX N/A
- HSDT $5.78
- Resistance Level
- SBLX N/A
- HSDT $6.57
- Average True Range (ATR)
- SBLX 0.00
- HSDT 0.35
- MACD
- SBLX 0.00
- HSDT 0.91
- Stochastic Oscillator
- SBLX 0.00
- HSDT 23.63
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.